These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2090071)

  • 1. [Systemic lytic state as marker of therapeutic success after rt-PA in bolus in myocardial infarction].
    Tranchesi Júnior B; Caramelli B; Gebara OC; Santos Filho RD; de Albuquerque CP; Matsumoto C; Bellotti G; Chamone D; Pileggi F
    Arq Bras Cardiol; 1990 Nov; 55(5):291-3. PubMed ID: 2090071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Kharash LM; Goldkhammer EI
    Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen.
    Seifried E; Oethinger M; Tanswell P; Hoegee-de Nobel E; Nieuwenhuizen W
    Thromb Haemost; 1993 Apr; 69(4):321-7. PubMed ID: 8497843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of thrombolytic therapy in acute myocardial infarction.
    Dutta AL; Mandal M
    J Indian Med Assoc; 1991 Nov; 89(11):322-4. PubMed ID: 1787323
    [No Abstract]   [Full Text] [Related]  

  • 8. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
    Van de Werf F; Ludbrook PA; Bergmann SR; Tiefenbrunn AJ; Fox KA; de Geest H; Verstraete M; Collen D; Sobel BE
    N Engl J Med; 1984 Mar; 310(10):609-13. PubMed ID: 6537987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients].
    Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality].
    Charbonnier B
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):697-705. PubMed ID: 1530411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elements of choice of thrombolytic agents in myocardial infarction].
    Samama M; Brochet E; Valère PE
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):721-7. PubMed ID: 1530414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator.
    Verstraete M; Bernard R; Bory M; Brower RW; Collen D; de Bono DP; Erbel R; Huhmann W; Lennane RJ; Lubsen J
    Lancet; 1985 Apr; 1(8433):842-7. PubMed ID: 2858711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial experiences with pro-urokinase in acute myocardial infarct].
    Schanzenbächer P; Huber J; Keller F; Kochsiek K
    Z Kardiol; 1987 Sep; 76(9):570-5. PubMed ID: 3122430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis (Consensus about post-myocardial infarction treatment)].
    Arq Bras Cardiol; 1995 Mar; 64(3):271-80. PubMed ID: 7487519
    [No Abstract]   [Full Text] [Related]  

  • 18. The safety and efficacy of streptokinase in coronary reperfusion in patients with acute myocardial infarction.
    Hu D
    Chin Med J (Engl); 1995 Apr; 108(4):291-4. PubMed ID: 7789218
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of treatment of acute myocardial infarction with thrombolytic therapy. Experiences in 437 patients in the coronary care unit of the National Institute of Cardiology "Ignacio Chavez"].
    Juárez Herrera U; Lasses y Ojeda LA; López MC; Chuquiure E; González Pacheco H; Carrillo Calvillo J; Martínez Sánchez C; Lupi Herrera E
    Arch Inst Cardiol Mex; 1998; 68(5):411-20. PubMed ID: 10365238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Repeat thrombolysis in acute myocardial infarction].
    Király C; Timár S
    Orv Hetil; 2001 Apr; 142(13):665-9. PubMed ID: 11338569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.